Atlas Trials

Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Clinical trial NCT04173988 · UNKNOWN

Trial details

NCT number
NCT04173988
Sponsor
Children's Hospital of Fudan University
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
ALL, Childhood B-Cell
Start date
2020-01-09
Primary completion
2024-10-20
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.